ENTITY
Guangzhou Baiyunshan Pharmaceutical Holdings

Guangzhou Baiyunshan Pharmaceutical Holdings (874 HK)

119
Analysis
Health Care • China
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.
more
bearish•Quantitative Analysis
•20 Nov 2022 11:28

A-H Premium Weekly (Nov 18th): China Longyuan, GF Securities, Great Wall Motor

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Longyuan, GF Securities, Great Wall Motor, COSCO...

Logo
404 Views
Share
bearish•Quantitative Analysis
•06 Nov 2022 14:03

A-H Premium Weekly (Nov 4th): First Tractor, Maanshan Iron

We analyzed A-H premium changes in the past week and highlight A-H premium changes for First Tractor, Maanshan Iron, Datang Intl, Cansino, Jushi,...

Logo
269 Views
Share
bullish•Consun Pharmaceutical
•16 Aug 2022 08:53

Consun Pharmaceutical (1681HK)- High-Priced Acquisition & Good Performance Show Big Upside Potential

Consun achieved amazing 2021 results and is undervalued. Wanbangde’s intention to acquire Consun at high price is a catalyst. Shares have big...

Logo
419 Views
Share
bearish•Quantitative Analysis
•03 Jul 2022 11:17

A-H Premium Weekly: Shandong Xinhua, Shenhua, Ganfeng Lithium

We highlight weekly A-H premium changes in Shandong Xinhua, Shenhua, Huaxin Cement, Ganfeng Lithium, Tsingtao Brewery, and Baiyunshan.

Logo
379 Views
Share
•23 Dec 2021 09:10

Guangzhou Baiyunshan Pharmaceutical Holdings (874.HK) - Conservative About the Outlook

This insight analyzed Baiyunshan’s 2021Q3 performance, the core business segments, the comparison with peers, the concerns on business transition,...

Logo
624 Views
Share
x